Auragent Biosciences

Auragent Biosciences

Auragent’s proprietary, ultrabright fluorescent probes can enhance the sensitivity of nearly any fluorescence-based assay

Arch Oncology

Arch Oncology

Clinical-stage immuno-oncology company focused on the discovery and development of potential best-in-class antibody therapies

Apath

Apath

Privately held company engaged in the commercial application of virology and viral genetics to assist pharmaceutical companies

Ancilia Biosciences

Ancilia Biosciences

Uses the power of CRISPR in the gut microbiome to treat chronic gastrointesttinal diseases

Acera Surgical

Acera Surgical

Acera’s lead product, Restrata, utilizes the advantages of synthetic construction to launch a new era in healing

M6P Therapeutics

M6P Therapeutics

Developing first-in-class, next-generation recombinant enzyme and gene therapies for lysosomal storage disorders by unlocking the potential of mannose 6-phosphate (M6P)

Viewing 1 - 80 of 100